Bio Protocol: IP tokens will be launched on Bio V2 and sold through Ignition Sales
ChainCatcher News, Bio Protocol posted on social media stating, "IP tokens will soon be launched on Bio V2 and will be sold through Ignition Sales, targeting BIO and BioXP holders. IPT represents a single atomic unit of science (such as a new compound, screening system, or therapeutic method), which can be generated by BioAgents, BioDAOs, or individual laboratories, and will return value to contributing nodes.
Just as AI-driven 'vibe coding' is transforming software engineering, 'vibe science' will soon change drug development as well. The next round of Bio V2 Ignition Sales is planned to take place next week on the Base platform."
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Sanctum launches Sanctum App, waitlist now open
Helios secures a $15 million investment commitment from Bolts Capital to support ETF Chain
Nasdaq-listed company Caliber: Has staked 75,000 LINK and will increase staking proportion
